GE's non-invasive SMS-EIT prototype system provides higher signal-to-noise ratio and greater sensitivity to continuously image pulmonary perfusion and ventilation.

Low-cost manufacturing platform for disposable, hospital-grade multi-parameter clinical monitoring devices.

Hydration status monitoring based on wearable sweat-based sensing

Imaging is an essential non-invasive tool for building disease understanding and characterization. Contrast agents or targeted imaging (molecular imaging) allow specific features to be delineated, such as vascularization, abnormal metabolism, or disease-specific biomarkers. GE Research has an active program developing molecular imaging agents that benefits from our strong capabilities in diagnostic imaging hardware and histopathogical technology for characterization of biomarkers in diseased tissue.

Developing cutting edge technologies in machine architectures, energy sources, sensing and controls for step-change in build size and speed, while assuring part quality.

Cell DIVE™ is a powerful and innovative commercial technology platform that enables a researcher to analyze single 5 um tissue section with up to 60 biomarker stains.

GE Research developed a novel method for automated tissue multiplexing.

Combining genetically variable peptides and DNA profiling to enable single contributor identification via proteomics for forensic applications.

For most of his career, Brian has focused on practical applications of gene delivery and cell therapy. At GE Research, Brian has led and contributed to programs related to cell therapy, gene therapy, pluripotent stem cell and hematopoietic cell expansion in bioreactors, closed system cell harvesting and passaging, novel approaches for DNA delivery into human cells, plasma medicine, and tool development for microfluidics, biomarker characterization, sterilization, and filtration.

This project aims to use quantitative-ultrasound (QUS) methods for detecting metastases in lymph nodes in a broad range of cancer types.